Evidence map›Paper›PMID 36557925›Full record

ArticleMolecules (Basel, Switzerland)2022

Screening and Mechanism of Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides in

Yihan Mu, Dongwei Liu, Huaping Xie, Xinyu Zhang, Xue Han, Zhaolin Lv

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Biodirected Screening and Preparation ofMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yihan MuCollege of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China.ORCID 0000-0001-9062-4914
Dongwei LiuCollege of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China.
Huaping XieUrban and Rural Development Research Center, Beijing 100835, China.
Xinyu ZhangCollege of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China.
Xue HanCollege of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China.
Zhaolin LvCollege of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China.
Beijing Forestry University · CNDevelopment Research Center · CN

Funding

Evaluation of characteristic and advantageous agricultural products in Gansu Province No, 2021HXKFSWXY021
6 · The paper itself

Abstract

Angiotensin-I-converting enzyme (ACE) inhibitors are used extensively to control hypertension. In this study, a computer-assisted experimental approach was used to screen ACE-inhibiting peptides from

Indexed as

Peptidyl-Dipeptidase ATandem Mass SpectrometryAngiotensin-Converting Enzyme InhibitorsAngiotensinsChromatography, LiquidComputersMolecular Docking SimulationPeptidesProtein HydrolysatesAngiotensin-Converting Enzyme InhibitorsAngiotensinsPeptidesPeptidyl-Dipeptidase AProtein Hydrolysatesangiotensin-I-converting enzymecomputer-assistedLC-MS/MSmolecular dockingX. sorbifolium

Identifiers

PMID36557925
PMCPMC9785712
OpenAlexW4312127239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.